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The protective role of melatonin has been investigated [1]. Some studies under-
lined its significant neuroprotective action with a role in aging processing. In patients 
with Alzheimer’s Disease, parallel to degenerative tissue changes, there was an over-
all decrease in the intensity of melatonin receptors in the pineal gland and occipital 
cortex [2]. Melatonin type 1 (MT1) and type 2 (MT2) receptors disclosed a quite wide-
spread distribution in different brain regions. Recently our group demonstrated that 
an animal model of hypercholesterolemia, such as ApoE-/- mice, is more suscepti-
ble to developing severe liver injury, suggesting that in addition to vascular disease, 
increased cholesterol products and oxidative stress may also play a role in accelerat-
ing aging in the liver [3]. On the basis of this consideration, the aim of our work is to 
characterize the distribution of MT1 and MT2 in brain of ApoE -/- mice at different 
age (6 weeks, 16 weeks and 60 weeks) together with senescence markers using immu-
nohistochemical technique to verify the role of these receptors in aging process. The 
results show an altered distribution of melatonin receptors and synaptic connectivity, 
indicating a process of aging in ApoE -/- mice and suggesting that melatonin treat-
ment may represent a new approach to reduce brain aging and degeneration.
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